Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
1 clinical trials · Condition
◉ Watch Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
| Record | Firm | Date |
|---|---|---|
| A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. (NCT06393738) | Arvinas Inc. | 2024-09-05 |
Track Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) automatically
Every clearance here is in the API, with alerts when new ones post.